Experimental model of hepatic fibrosis following repeated periportal necrosis induced by allylalcohol

S A Jung1, Y H Chung, N H Park

  • 1Dept. of Internal Medicine, Asan Medical Center, Ewha Womans University College of Medicine, Seoul, Korea.

Abstract

Insights

Repetitive allylalcohol injections in rats effectively induced hepatic fibrosis, particularly in the periportal zone. This model shows increased collagen and transforming growth factor-beta1 (TGF-β1) mRNA, useful for studying liver fibrosis.

Area of Science:

  • Hepatology
  • Fibrosis Research
  • Animal Models

Background:

  • Chronic viral hepatitis often features periportal hepatic necrosis and fibrosis.
  • A simple rat model for hepatic fibrosis was needed, mimicking periportal damage.

Purpose of the Study:

  • To establish a novel, simple rat model of hepatic fibrosis.
  • To induce repetitive periportal necrosis using allylalcohol.

Main Methods:

  • Adult male rats received intraperitoneal allylalcohol injections twice weekly.
  • Liver tissues were analyzed for fibrosis extent, collagen content, and transforming growth factor-beta1 (TGF-β1) mRNA expression via RT-PCR.
  • Control rats received normal saline.

Main Results:

  • Moderate to severe periportal fibrosis was observed in rats after 8 weeks of allylalcohol treatment.
  • Significant correlations were found between fibrosis extent, collagen levels, and TGF-β1 mRNA expression.
  • TGF-β1 mRNA levels were upregulated in liver tissues with significant fibrosis.

Conclusions:

  • Repetitive allylalcohol injections (0.62 mmol/kg, twice weekly for 8 weeks) reliably induce hepatic fibrosis in rats.
  • This model exhibits TGF-β1 overexpression and is suitable for studying predominantly periportal fibrosis.
  • The model aids research into liver fibrosis mechanisms and potential therapies.